No insider purchase over the last 90 days. The latest was filed 04 Jan 2016.
Sequenom Inc is a listed company. Its insiders report their share dealings to SEC (Form 4). The past year has been quiet: not a single insider filing for Sequenom Inc. The previous disclosure was published on 11 February 2016.
Other companies in the same market with recent insider buying flagged by our signals: Relmada Therapeutics, Inc. and Uber Technologies, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
FY ended December 2015 · cache
25 of 27 declarations
Sequenom Inc is a company focused on developing non-invasive genetic testing. It is listed on the NASDAQ under the ticker SEQU.